Classification analysis of P-glycoprotein substrate specificity.
about
Killing them with kindness? In-hive medications may inhibit xenobiotic efflux transporters and endanger honey beesOvercoming cisplatin resistance by mTOR inhibitor in lung cancer.A multi-system approach assessing the interaction of anticonvulsants with P-gpIdentification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission TomographyA dual-fluorescence high-throughput cell line system for probing multidrug resistance.Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid.Pluronics and MDR reversal: an update.In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosinOptimization of the antitumor activity of sequence-specific pyrrolobenzodiazepine derivatives based on their affinity for ABC transporters.Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in miceDevelopment of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistanceReproducibility of quantitative (R)-[11C]verapamil studies.Role of efflux pumps and metabolising enzymes in drug delivery.Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene.P-glycoprotein function at the blood-brain barrier: effects of age and gender.The road map to oral bioavailability: an industrial perspective.The rise of PAMPA.Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.Modeling kinetics of subcellular disposition of chemicals.P-glycoprotein efflux transporter activity often displays biphasic dose-response relationships.P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.Effect of potential amine prodrugs of selective neuronal nitric oxide synthase inhibitors on blood-brain barrier penetration.The right compound in the right assay at the right time: an integrated discovery DMPK strategy.The significance of acid/base properties in drug discoveryImproving the prediction of drug disposition in the brain.In vitro prediction of brain penetration - a case for free thinking?Strategies to assess blood-brain barrier penetration.Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.Therapeutic potential of nanocarrier for overcoming to P-glycoprotein.Implicating ABC Transporters in Insecticide Resistance: Research Strategies and a Decision Framework.Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.The forgotten or underestimated relevance of biopharmaceutical-based assessments for the oral absorption studies of oxime reactivators.Impact of the Recent Mouse P-Glycoprotein Structure for Structure-Based Ligand Design.Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability.Use of shape similarities for the classification of P-glycoprotein substrates and nonsubstrates.Discovery DMPK: changing paradigms in the eighties, nineties and noughties.Discovery of anthranilamides as a novel class of inhibitors of neurotropic alphavirus replication.In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies.In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids.
P2860
Q21134979-04129D8E-D997-4F2C-9097-D9AD0E50C0ACQ24815638-BA09764B-20FD-4825-8582-7C5B8FDA68F2Q28533527-C45DE213-BA61-4D85-AC51-A5C2D1C255DBQ28553692-6FDB9B17-A621-4F82-983D-02A9610E08AFQ33472881-8CE69F6B-6780-4A01-883A-0C6F1783EFC7Q33654580-F54669AA-2FB7-4E98-A952-7787B0F23AE9Q34005678-36F7B42A-B6A6-46C1-921B-AF7031F4C86FQ34005841-42236360-4DE1-4509-A966-979FB7910AF6Q34293696-5BDCA6A8-A2F1-469B-A49A-21CD37579FBFQ34529241-90AEBB60-C772-464C-8DB7-409FDD06B55EQ35000329-E1709726-84CE-45D5-B64D-81EE24491F2AQ35742284-E4D93B6A-C3AC-4E2E-886E-949047C1C5E8Q36316872-2CE2D337-5F61-4726-827A-92C6F4E4BE53Q36353785-2820A77D-6653-47F6-A653-78CB504AA09BQ36382013-8B6A3BBF-959F-42EC-941D-DCAAD2589999Q36543116-B287A437-9A92-4E2A-9063-42013F34AD91Q36572610-DC56D490-1045-4FE9-88BE-801C643C9700Q36909311-CA1871B8-EFB4-4DF8-8A03-776628141619Q37194304-E8253549-5E07-477A-954B-AC0FD5CD9295Q37196500-F3E803FC-86D9-46EA-8569-8C4831FF0629Q37355679-2C591311-8FDA-4CF7-B0BD-230A11F0A417Q37416804-ACEEF75F-5015-411A-A849-448B776DD4DEQ38018653-AA0E1CF9-12D9-4990-BB7E-61C0DC4F1330Q38055676-A90229A5-35E8-44FC-82CF-8EB26A3E6AD6Q38072077-601CFB60-92E9-40A4-8CB3-8ABA25F5EFB0Q38090652-8726D1CA-FB58-40D6-A9A4-86FBA7C14665Q38090672-697388E4-D844-4DC6-B1D6-86DD84A125A1Q38117056-FF138E53-BC66-4F92-BDBD-B97F5F9A1C69Q38237724-11AC688D-B9FB-4472-BAC0-CB02887DAD8FQ38740941-ECFAC40C-C719-46CD-8444-28A70D617BF9Q38810544-903E7D99-BDAB-41DA-BBAB-A404AF3F23E9Q38825239-252E9853-C7DD-4033-BE94-3D08A4063C5DQ38910024-1A16CBFB-29B2-41BB-B425-51829BC7F6D2Q39490266-5DA5A83A-ABA2-4778-8911-99437F2DD6AFQ39535338-C767D840-ACDC-40FB-99E8-2244BCF42CA8Q39722405-EBBDDD7C-7F39-4964-944E-759D0624244FQ39998934-30E5867B-722A-4BD8-A3C3-DEDAAC6D7E8FQ41449946-DE758887-66CF-40A2-B2E1-7A6A8B2B76F2Q46111336-3BDF61D3-A286-4994-8844-D4E86DF3DAE7Q47823537-D5DFFE64-8C73-4000-AE21-428B0D30DC17
P2860
Classification analysis of P-glycoprotein substrate specificity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Classification analysis of P-glycoprotein substrate specificity.
@en
Classification analysis of P-glycoprotein substrate specificity.
@nl
type
label
Classification analysis of P-glycoprotein substrate specificity.
@en
Classification analysis of P-glycoprotein substrate specificity.
@nl
prefLabel
Classification analysis of P-glycoprotein substrate specificity.
@en
Classification analysis of P-glycoprotein substrate specificity.
@nl
P2093
P2860
P1476
Classification analysis of P-glycoprotein substrate specificity.
@en
P2093
Alanas Petrauskas
Alex Avdeef
Pranas Japertas
Remigijus Didziapetris
P2860
P304
P356
10.1080/10611860310001648248
P577
2003-08-01T00:00:00Z